NCT07260708 2026-04-21Clinical Trial of TQB2922 Injection (Subcutaneous Injection) in Patients With Advanced CancersChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 1 Recruiting42 enrolled